RxDoctor Payments Data

Djavlon Khakimov, DPM

Foot & Ankle Surgery · Morristown, NJNPI 1285139261

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 63.7% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,555, 5.3 times the $292 reported in 2021.

$3,375in general payments, 2019–2025

Across 54 payments — averaging $62.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Paragon 28, Inc.$666
  • Cardiovascular Systems Inc.$218
  • Zimmer Biomet$133
  • Inari Medical, Inc.$133
  • Smith+Nephew$46
  • plus $27 from 1 others

What the payments were for

  • Food & beverage$3,375100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,375 in reported general payments places this provider in the 60th percentile of 542 foot & ankle surgery providers in New Jersey.

See all foot & ankle surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024
$63,676
Medicare patients
97
Services billed
679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium53$7,487
Ketoconazole240$3,134
Ammonium Lactate42$1,004
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip51$896
Mupirocin84$703
Naproxen54$460
Cephalexin65$438
Ciclopirox13$363
Terbinafine Hcl23$269
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen60$240
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$192
Meloxicam44$77
Gabapentin11$50

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Morristown

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →